Literature DB >> 23972307

Diagnostic fundus autofluorescence patterns in achromatopsia.

Abigail T Fahim1, Naheed W Khan, Sarwar Zahid, Ira H Schachar, Kari Branham, Susanne Kohl, Bernd Wissinger, Victor M Elner, John R Heckenlively, Thiran Jayasundera.   

Abstract

PURPOSE: To describe the unique diagnostic fundus autofluorescence (FAF) patterns in patients with achromatopsia and the associated findings on optical coherence tomography (OCT).
DESIGN: Observational case series.
METHODS: We evaluated 10 patients with achromatopsia by means of best-corrected visual acuity (BCVA), ophthalmoscopy, Goldmann visual field, full-field electroretinography (ffERG), OCT, and FAF photography. FAF patterns were compared with patient age and foveal changes on OCT.
RESULTS: Patients fell into two dichotomous age groups at the time of evaluation: six patients ranged from 11 to 23 years of age, and 3 patients ranged from 52 to 63 years of age. All patients had severely reduced photopic ffERG responses, including those exhibiting preserved foveal structure on OCT. The younger patients had absent to mild foveal atrophy on OCT, and four of the six demonstrated foveal and parafoveal hyperfluorescence on FAF. In addition, a 7-month-old child with compound heterozygous mutations in CNGA3 demonstrated similar foveal hyperfluorescence. The older patients demonstrated advanced foveal atrophy and punched-out foveal hypofluorescence with discrete borders on FAF imaging corresponding to the area of outer retinal cavitation on OCT.
CONCLUSIONS: Foveal hyperfluorescence is an early sign of achromatopsia that can aid in clinical diagnosis. In our cohort, patients with achromatopsia demonstrated age-dependent changes in FAF, which are likely to be progressive and to correlate with foveal atrophy and cavitation on OCT. This finding may be useful in charting the natural course of the disease and in defining a therapeutic window for treatment.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23972307     DOI: 10.1016/j.ajo.2013.06.033

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

1.  Multimodal imaging of foveal cavitation in retinal dystrophies.

Authors:  Maurizio Battaglia Parodi; Maria Vittoria Cicinelli; Pierluigi Iacono; Gianluigi Bolognesi; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

2.  Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia.

Authors:  Eyal Banin; Elisha Gootwine; Alexey Obolensky; Raaya Ezra-Elia; Ayala Ejzenberg; Lina Zelinger; Hen Honig; Alexander Rosov; Esther Yamin; Dror Sharon; Edward Averbukh; William W Hauswirth; Ron Ofri
Journal:  Mol Ther       Date:  2015-06-19       Impact factor: 11.454

3.  Potential contribution of ryanodine receptor 2 upregulation to cGMP/PKG signaling-induced cone degeneration in cyclic nucleotide-gated channel deficiency.

Authors:  Fan Yang; Hongwei Ma; Michael R Butler; Xi-Qin Ding
Journal:  FASEB J       Date:  2020-03-16       Impact factor: 5.191

4.  Flicker cone function in normal and day blind sheep: a large animal model for human achromatopsia caused by CNGA3 mutation.

Authors:  Raaya Ezra-Elia; Eyal Banin; Hen Honig; Alexander Rosov; Alexey Obolensky; Edward Averbukh; William W Hauswirth; Elisha Gootwine; Ron Ofri
Journal:  Doc Ophthalmol       Date:  2014-09-10       Impact factor: 2.379

5.  Structural and genetic assessment of the ABCA4-associated optical gap phenotype.

Authors:  Kalev Nõupuu; Winston Lee; Jana Zernant; Stephen H Tsang; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-09       Impact factor: 4.799

6.  Novel mutations in the gene for α-subunit of retinal cone cyclic nucleotide-gated channels in a Japanese patient with congenital achromatopsia.

Authors:  Kazuki Kuniyoshi; Sanae Muraki-Oda; Hisao Ueyama; Futoshi Toyoda; Hiroyuki Sakuramoto; Hisakazu Ogita; Motohiro Irifune; Shuji Yamamoto; Akira Nakao; Kazushige Tsunoda; Takeshi Iwata; Masahito Ohji; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2016-02-05       Impact factor: 2.447

7.  Occult macular dystrophy with bilateral chronic subfoveal serous retinal detachment associated with a novel RP1L1 mutation (p.S1199P).

Authors:  Hidenori Takahashi; Takaaki Hayashi; Hiroshi Tsuneoka; Tadashi Nakano; Hisashi Yamada; Satoshi Katagiri; Yujiro Fujino; Yasuo Noda; Miwako Yoshimoto; Hidetoshi Kawashima
Journal:  Doc Ophthalmol       Date:  2014-05-17       Impact factor: 2.379

8.  A prospective longitudinal study of retinal structure and function in achromatopsia.

Authors:  Jonathan Aboshiha; Adam M Dubis; Jill Cowing; Rachel T A Fahy; Venki Sundaram; James W Bainbridge; Robin R Ali; Alfredo Dubra; Marko Nardini; Andrew R Webster; Anthony T Moore; Gary Rubin; Joseph Carroll; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-07       Impact factor: 4.799

Review 9.  Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium.

Authors:  Debra A Thompson; Robin R Ali; Eyal Banin; Kari E Branham; John G Flannery; David M Gamm; William W Hauswirth; John R Heckenlively; Alessandro Iannaccone; K Thiran Jayasundera; Naheed W Khan; Robert S Molday; Mark E Pennesi; Thomas A Reh; Richard G Weleber; David N Zacks
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-09       Impact factor: 4.799

10.  Monitoring progression of retinitis pigmentosa: current recommendations and recent advances.

Authors:  Moreno Menghini; Jasmina Cehajic-Kapetanovic; Robert E MacLaren
Journal:  Expert Opin Orphan Drugs       Date:  2020-03-02       Impact factor: 0.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.